MindWalk Holdings HYFT
NASDAQ HYFT
$1.31 +0.18 (+15.93%)
At close: Sep 17, 2026 · 4:00 PM EDT

MindWalk Holdings (HYFT) Liabilities and Shareholders Equity (2020 - 2026)

MindWalk Holdings' (HYFT) quarterly Liabilities and Shareholders Equity came in at $15.6 million in Q2 2026, down 50.07% year-over-year from $31.2 million in Q2 2025, and down 5.86% quarter-over-quarter from $16.6 million in Q1 2026.

Analysis

MindWalk Holdings (HYFT) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

MindWalk Holdings (HYFT) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $15.6 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 50.07% year-over-year to $15.6 million in Q2 2026; TTM through Apr 2026 was $80.6 million, a 46.43% decrease from a year earlier, with the FY2026 full-year figure at $15.5 million, down 51.44% from the prior year.
  • Liabilities and Shareholders Equity was $15.6 million for Q2 2026 at MindWalk Holdings, down from $16.6 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $73.9 million in Q2 2022 and troughed at $15.6 million in Q2 2026.
  • A 5-year average of $44.9 million and a median of $44.4 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity jumped 39.02% in 2022 and sank 57.15% in 2025, its largest moves.
  • Over 5 years, Liabilities and Shareholders Equity stood at $62.3 million in 2022, then slipped by 10.5% to $55.8 million in 2023, then fell by 21.25% to $43.9 million in 2024, then slumped by 57.15% to $18.8 million in 2025, then slipped by 17.13% to $15.6 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $15.6 million (Q2 2026), $16.6 million (Q1 2026), and $18.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 29.88 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 2.06 Bn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 16.40 Bn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 7.53 Bn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 2.71 Bn
6 Evotec SE 574.75 Mn 148.87 Mn - 1.83 Bn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 990.05 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 33.29 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 12.42 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - 3.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 15.59 Mn
Jan 31, 2026 16.56 Mn
Oct 31, 2025 18.82 Mn
Jul 31, 2025 29.66 Mn
Apr 30, 2025 31.23 Mn
Jan 31, 2025 32.08 Mn
Oct 31, 2024 43.91 Mn
Jul 31, 2024 43.31 Mn
Apr 30, 2024 44.24 Mn
Jan 31, 2024 58.21 Mn
Oct 31, 2023 55.76 Mn
Jul 31, 2023 57.38 Mn
Apr 30, 2023 57.51 Mn
Jan 31, 2023 61.12 Mn
Oct 31, 2022 62.31 Mn
Jul 31, 2022 62.16 Mn
Apr 30, 2022 73.94 Mn
Jan 31, 2022 44.60 Mn
Oct 31, 2021 47.99 Mn
Jul 31, 2021 52.45 Mn